[1]
P. H. Souza e Silva, “EFFECT OF TIRZEPATIDE ON THE REDUCTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Editora, pp. 600–613, May 2026, doi: 10.56238/sevened2026.020-037.